How Resveratrol Helps Regulate Blood Sugar

One has to be impressed by nature’s power to bolster health.  As drug companies try to document that one of their concoctions can manipulate a single parameter of health while hopefully not causing too much damage, nature provides potent remedies that simultaneously influence multiple aspects of health while being free of adverse side effects.  There simply is no comparison.  The more science looks into the mechanisms of natural remedies the more impressive they become.  Resveratrol is a case in point.

Resveratrol is best known for its activation of the SIRT1 Considered the "longevity protein" known for its life spanning effects. It has been shown to inhibit cancer and promote longevity. gene that is associated with longevity.  SIRT1 Considered the "longevity protein" known for its life spanning effects. It has been shown to inhibit cancer and promote longevity. is also activated by dietary restriction, and shut down when a person eats too much, which is why many people are speeding their aging process and shortening their lives.  Resveratrol works best when you aren’t overeating, because it helps rejuvenate your SIRT1 Considered the "longevity protein" known for its life spanning effects. It has been shown to inhibit cancer and promote longevity. gene fitness.  Once SIRT1 Considered the "longevity protein" known for its life spanning effects. It has been shown to inhibit cancer and promote longevity. is activated it has powerfully beneficial effects on a wide variety of gene signals associated with healthy metabolism.

Several new resveratrol Natural phenol or type of antioxidant found in red grapes, red wine. Research has shown beneficial effects as anti-cancer and anti-inflammatory agents along with supporting healthy blood sugar and cardiovasculature function. studies add to several previous studies supporting the role of resveratrol Natural phenol or type of antioxidant found in red grapes, red wine. Research has shown beneficial effects as anti-cancer and anti-inflammatory agents along with supporting healthy blood sugar and cardiovasculature function. to help improve blood sugar metabolism.  One of the studies took immune cells from diabetic patients and found they lacked SIRT1 Considered the "longevity protein" known for its life spanning effects. It has been shown to inhibit cancer and promote longevity. activity compared to immune cells from people with normal blood sugar.  These SIRT1 Considered the "longevity protein" known for its life spanning effects. It has been shown to inhibit cancer and promote longevity. deficient cells also had increased rates of free radical damage.  The researchers showed that resveratrol Natural phenol or type of antioxidant found in red grapes, red wine. Research has shown beneficial effects as anti-cancer and anti-inflammatory agents along with supporting healthy blood sugar and cardiovasculature function. could boost SIRT1 Considered the "longevity protein" known for its life spanning effects. It has been shown to inhibit cancer and promote longevity. levels to normal, and stop the free radical damage, as SIRT1 Considered the "longevity protein" known for its life spanning effects. It has been shown to inhibit cancer and promote longevity. activation influenced several other gene signals to improve metabolism.

The next study looked into the impact of resveratrol Natural phenol or type of antioxidant found in red grapes, red wine. Research has shown beneficial effects as anti-cancer and anti-inflammatory agents along with supporting healthy blood sugar and cardiovasculature function. in an animal model of type 2 diabetes.  Resveratrol decreased blood sugar and triglycerides while boosting levels of the all important blood sugar regulating hormone adiponectin Protein hormone that modulates metabolism including glucose and fatty acid catabolism. High levels are associated with low body fat. .  Resveratrol boosted cellular levels of AMP-activated protein kinase (AMPK), an important cellular signal involved with the biological clock and use of energy within a cell.  In other words, when you feel fatigued or jet-lagged your AMPK is on the blink.  The net result of boosting AMPK was to significantly improve the liver’s ability to metabolize sugar that resulted in lower blood levels of hemoglobin A1c (a key marker of improved glucose metabolism).  Resveratrol even helped the liver and muscles dispose of calories as heat, a natural metabolic boost for improved calorie burning, especially in those who are overweight. 

Yesterday I mentioned how green tea helps protect against high blood sugar.  While both resveratrol Natural phenol or type of antioxidant found in red grapes, red wine. Research has shown beneficial effects as anti-cancer and anti-inflammatory agents along with supporting healthy blood sugar and cardiovasculature function. and green tea help lower free radical damage, much of their metabolic assistance influences different genes, all in support of better metabolism.  Any person with blood sugar concerns should follow the Leptin Diet and employ a variety of natural support that can help guide metabolism into a healthy direction over time. 

Resveratrol continues to build on its image as an anti-aging nutrient.  We know from studies in healthy centenarians that optimal blood sugar metabolism is vital to a long life.  Resveratrol is an important tool in the longevity toolbox.

Share:
Supplements that contain Resveratrol
Related Entries:

Scientists Tout Resveratrol as a Primary Nutrient for Cardio Health
Can Resveratrol Help Offset a Sedentary Life?
Human Study Proves Resveratrol Lowers Inflammatory Gene Signaling
Resveratrol Helps Improve the Fitness of Your Fat
Is Resveratrol the Fountain of Youth?

Other Weight Loss News

Pulling Data...

View the Original article

Greater diet-induced obesity in rats consuming sugar solution during the inactive period

ScienceDaily (July 10, 2012) — New research presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB) suggests that, not only the amount and type of food eaten but the time of day it is eaten is important in contributing to obesity.

See Also:Health & MedicineDiet and Weight LossObesityFitnessPlants & AnimalsFoodAnimalsAgriculture and FoodReferenceSouth Beach dietDetox dietBlood sugarHigh fructose corn syrup

Previous studies have shown that when mice consumed all of their calories during their inactive period they gained more weight than when they consumed the same amount of calories during their active period. A team led by Drs. Susanne la Fleur and Andries Kalsbeek at the Academic Medical Center of the University of Amsterdam wished to investigate how certain components of the diet, such as sugar or fat, contributed to differences in weight gain during different times of the day.

To address this question Dr. Joelle Oosterman gave rats either rodent chow or chow plus either saturated fat or a sugar solution. One group was allowed to consume the diets freely whereas the other groups were only allowed to eat either the fat or sugar during their inactive period. They found that rats consuming all of their sugar solution in the inactive period gained more weight than rats consuming all their sugar solution during the active period, even though their total caloric intake was the same. They also gained more weight than rats consuming the saturated fat solely during the inactive period. The greater body weight gain in rats consuming sugar in the inactive period was associated with less heat production.

This research suggests that there are differences in the impact sugar drinking can have on body weight gain, depending on when in the day it is consumed. Dr. Oosterman commented, "In today's society where snacks containing saturated fat and beverages containing lots of sugar are readily available to people, it is important to understand the impact these food components have on energy balance. Although there is a lot of attention for the content of the food people consume, little attention is been given to the best or worst timing for certain foods to be consumed."

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

View the Original article

Cinnamon Improves Regulation of Blood Sugar

An analysis of six high quality human studies on cinnamon consumption and blood sugar has confirmed that intake of cinnamon has a beneficial effect on fasting blood sugar and hemoglobin A1c (HbA1c). 

The best supplemental form of cinnamon is called Cinnulin PF, a special water-soluble extract originally developed at the U.S. Department of Agriculture.  It filters out some components of cinnamon that can be toxic when taken at high doses.  It is also concentrated in the most bioactive compounds in cinnamon called doubly linked Type-A Polymers. 

Cinnamon helps enhance the flow of sugar in metabolism.  It works to improve glucose transport by helping insulin signaling.  Of course, if a person continues to eat too much then it isn’t likely to do much.  However, if one consistently exercises, and follows the Leptin Diet—giving their metabolism a chance—cinnamon is a useful tool that can help correct a stressed-out blood sugar metabolism.

Share:
Supplements that contain cinnamon
Related Entries:

Cinnamon as an Anti-Aging Skin Nutrient
Tumeric (Curcumin) and Cinnamon Lower Insulin and Triglycerides
Cinnamon Extract Improves Antioxidant Function & Blood Sugar
Cinnamon in the Prevention of Type II Diabetes and the Metabolic Syndrome
Cinnamon Improves Multiple Genes Relating to Blood Sugar and Fatty Acid Metabolism
Cinnamon Lowers Hemoglobin A1C in Type II Diabetics

Other Weight Loss News

Pulling Data...

View the Original article

Diabetes: Tighter control of blood sugar prevents nerve condition, but at what risk?

ScienceDaily (June 13, 2012) — Aggressive control of blood sugar levels in diabetes can help to prevent a painful condition affecting patients' nerves, according to a new systematic review in The Cochrane Library. However, the review suggests that optimal target levels need to be established to prevent serious complications.

See Also:Health & MedicineDiabetesNeuropathyPersonalized MedicineHormone DisordersDiet and Weight LossBirth ControlReferenceBlood sugarDiabetic dietHyperglycemiaDiabetes mellitus type 2

People with diabetes control their blood sugar levels through insulin injections, diet and drugs, to compensate for their bodies producing too little insulin (type 1 diabetes) or becoming resistant to insulin (type 2 diabetes). Up to half of people with diabetes develop a disabling condition called diabetic neuropathy, which affects nerves in the feet and legs, making them feel tingly, numb, painful or weak. It is possible to prevent neuropathy by strict control of blood sugar levels through a number of ways including different insulin regimens and diet modification, but evidence for the effects of this approach, known as enhanced glucose control, has not been systematically reviewed until now.

The results analysed in the review are drawn from six studies investigating the risk of neuropathy in people who received enhanced glucose control treatments including extra insulin injections, antidiabetic drugs, and diet changes. The review looked at evidence in type 1 and type 2 diabetes separately. In two studies involving 1,228 people with type 1 diabetes significantly fewer people developed neuropathy each year with enhanced glucose control treatment compared with routine care. In four studies involving 6,669 people with type 2 diabetes the reduction in new cases of neuropathy was small and not statistically significant.

"Overall, this evidence suggests that a more aggressive approach to controlling sugar levels can be effective in delaying the onset of neuropathy in diabetes," said lead author of the review, Brian Callaghan, M.D., Assistant Professor in the Department of Neurology at the University of Michigan in Ann Arbor, Michigan, US. "The results also highlight the differences between type 1 and type 2 diabetes. The less dramatic effect of enhanced glucose control in type 2 diabetes may indicate that other factors, besides high glucose levels, may be important in causing nerve damage in these patients."

However, the risk of adverse effects associated with the treatment, including hypoglycaemia, was higher with enhanced glucose control. The researchers say further research is needed to optimise target levels for safe treatments that will both prevent neuropathy and minimise serious side effects.

"Although these results show clear benefits for preventing neuropathy in people with diabetes, they should be weighed against potential adverse effects," said Callaghan. "Future studies must establish target levels for glucose control that will balance benefits and side effects."

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

View the Original article

High Blood Sugar May Make Pneumonia Deadlier

HealthDay – 4 hrs ago WEDNESDAY, May 30 (HealthDay News) -- Elevated blood sugar levels may help predict death in pneumonia patients, researchers say.

The new study included nearly 6,900 patients, average age 60, with community-acquired pneumonia who were admitted to hospitals and private practices in Austria, Germany and Switzerland between 2003 and 2009.

Community-acquired pneumonia, one of the leading infectious diseases in industrialized nations, is a major cause of illness and death, according to background information in the study published online May 29 in the journal BMJ.

Compared to patients with normal glucose levels at admission, those with elevated levels had a higher risk of death within 28 and 90 days. The higher a patient's glucose levels, the greater the risk of death, the investigators said in a journal news release.

The death rate within 90 days was 3 percent for patients without diabetes and normal glucose levels, 10 percent for those without diabetes but with elevated glucose levels, and 14 percent for patients with diabetes, regardless of their glucose levels on admission, the study revealed.

The findings show the necessity of glucose testing and close glucose monitoring after patients with community-acquired pneumonia are discharged from hospital, in order to diagnose diabetes and to prevent further complications, concluded Dr. Philipp Lepper, of the University Hospital of Saarland in Germany, and colleagues.

More information

The U.S. National Heart, Lung, and Blood Institute has more about pneumonia.

View the Original article

Experimental bariatric surgery controls blood sugar in rodents with diabetes via novel sensing signals in gut

ScienceDaily (May 20, 2012) — For the first time, scientists at the Toronto General Hospital Research Institute have shown that an experimental bariatric surgery can lower blood sugar levels in rats with type 1 diabetes.

See Also:Health & MedicineDiabetesDiet and Weight LossWounds and HealingHypertensionObesityHormone DisordersReferenceBlood sugarHyperglycemiaGlycemic indexDiabetic diet

A team led by Dr. Tony Lam and Dr. Danna Breen, a post- doctoral fellow in the lab of Dr. Lam, used a rat model to study novel nutrient-sensing signals in the jejunum, located in the middle of the intestine. Dr. Lam and his team demonstrate that duodenal-jejunal bypass surgery activates novel nutrient-sensing signals in the jejunum and rapidly lowers blood sugar levels in non-obese rats with uncontrolled diabetes. DJB surgery is a type of bariatric surgery which excludes the duodenum and proximal jejunum, the first section of the small intestine, and instead redirects food into the distal jejunum, the middle to last section of the intestine. This latter section of the intestine, as demonstrated by Dr. Lam and his team, can sense glucose and signal to the brain to let the liver know that it must lower glucose production, leading to better control of blood sugar in the diabetic rats.

The study showed for the first time that a surgical intervention induces a rapid glucose-lowering effect in non-obese type 1 uncontrolled diabetic rats, independent of a reduction in food intake and body weight as well as changes in blood insulin levels.

The research was published in a paper entitled, "Jejunal nutrient sensing is required for duodenal-proximal jejunal bypass surgery to lower glucose levels in uncontrolled diabetes," in the May 20, 2012 on-line edition of the international journal Nature Medicine.

"We report that shortly after a meal, the influx of nutrients into the jejunum of DJB surgical diabetic rats activates novel sensing mechanisms to lower blood sugar levels. Importantly, this occurs in the presence of insulin-deficiency and is independent of weight loss," says Dr. Lam, who holds The John Kitson McIvor (1915 -- 1942) Endowed Chair in Diabetes Research and the Canada Research Chair in Obesity at the Toronto General Research Institute and the University of Toronto. He is also Associate Director of Research at the Banting and Best Diabetes Centre at the University of Toronto.

Currently, patients with Type 1 diabetes lower their glucose through insulin injections (usually several times a day) and must regularly monitor blood glucose levels. High or uncontrolled glucose levels can result in damage to eyes, nerves and kidneys and increase the risk of heart attack, stroke, blindness, erectile dysfunction, foot problems and amputations. Many laboratories around the world are in a race to find alternative and effective ways in which to lower and better control glucose levels because of the severe complications which can result from high sugar levels.

Dr. Lam's laboratory is a world pioneer in exploring the role of the gut in regulating blood sugar. "The gut is an easier and therefore more promising therapeutic target in regulating blood sugar than the brain or liver, due to their potential side effects, " says Dr. Danna Breen, who is the lead author in the study. Dr. Breen adds that this type of surgery may potentially have therapeutic value in lowering glucose (sugar) levels in non-obese individuals with type 2 or 1 diabetes, but that many more years of future studies are required to determine whether this approach is effective and safe in humans who have diabetes.

In healthy individuals, insulin is a hormone whose primary role is to regulate blood sugar. It is produced by cells located on the pancreas in response to sugar intake, and it acts to bring blood sugar to appropriate levels, allowing the body to have the energy it needs to function properly. In persons with type 1 diabetes, the pancreas does not produce insulin, resulting in elevated blood sugar levels due to lack of insulin which cannot signal to the liver to reduce sugar production. People with type 1 diabetes need to take daily insulin shots and carefully monitor their blood sugar levels.

"If new medicines or surgical interventions can be developed that stimulate this sensing mechanism in the gut, we may have an effective and alternative way of slowing down the body's production of sugar, thereby lowering blood sugar levels in diabetes," says Dr. Lam, who is also an Associate Professor of Medicine and Physiology at the University of Toronto. Other ongoing studies of Dr. Lam's lab reveal novel molecular targets in the gut that effectively lower blood sugar in obesity and type 2 diabetes.

Studies reported in the New England Journal of Medicine this year have challenged medical therapy as the prevailing method of treating patients with type 2 diabetes. Two studies reported that bariatric surgery induced remission in severely obese patients with type 2 diabetes, and was associated with significant improvement in metabolic control over and above medical therapy, both conventional and intensive. An accompanying April 26, 2012 editorial by Drs. Zimmet and Alberti, states that "surgeons may now be able to claim greater success in achieving metabolic control," in these patients, although long-term studies with greater numbers of patients still need to be completed. No studies have yet reported on surgical interventions as treatments for patients with type 1 diabetes.

"More than two million Canadians have diabetes. Diabetes is an epidemic in Canada and around the world that is growing at an alarming rate," says Dr. Philip M. Sherman, Scientific Director of the Institute of Nutrition, Metabolism and Diabetes at the Canadian Institutes of Health Research. "Since many people are undergoing bariatric surgery in an attempt to manage morbid obesity and the associated health problems, such as diabetes, it is critical that we understand how it works. The Canadian Institutes of Health Research is pleased to support Dr. Lam's work which increases our understanding and may offer a new approach to managing morbidity and premature mortality resulting from this illness."

Working with rats, Drs. Lam, Breen and colleagues designed and performed a series of elegant experiments on two different groups of rats: rats whose insulin-producing pancreatic islet cells were destroyed by toxins; and genetically-altered rats which experienced spontaneous autoimmune destruction of islet cells -- similar to what happens in humans with type 1 diabetes.

Non-obese rats induced with uncontrolled diabetes or autoimmune type 1 diabetes had an experimental DJB surgery, a variation of the Roux-en-Y gastric bypass, the most common surgical method currently used to treat obese patients. Two days after DJB surgery, blood sugars were normal in the insulin-deficient diabetic rats.

Dr. Breen emphasized that further studies need to be undertaken to determine the long-term effects of this intervention in rodents, as well as to ensure the safety and efficacy of this procedure in humans.

Other researchers involved in the study include Brittany A. Rasmussen, Andrea Kokorovic and Grace W.C. Cheung from the Toronto General Research Institute and the Department of Physiology, University of Toronto; and Dr. Rennian Wang, from the Departments of Physiology and Pharmacology, University of Western Ontario.

The work was funded by the Canadian Institutes of Health Research, as well as a fellowship from the University Health Network and the Banting and Best Diabetes Centre, University of Toronto.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

View the Original article

Liver fat gets a wake-up call that maintains blood sugar levels

ScienceDaily (May 6, 2012) — A Penn research team, led by Mitchell Lazar, MD, PhD, director of the Institute for Diabetes, Obesity, and Metabolism at the Perelman School of Medicine, University of Pennsylvania, reports in Nature Medicine that mice in which an enzyme called histone deacetylase 3 (HDAC3) was deleted had massively fatty livers, but lower blood sugar, and were thus protected from glucose intolerance and insulin resistance, the hallmark of diabetes.

See Also:Health & MedicineDiabetesObesityDiet and Weight LossLiver DiseaseCholesterolFitnessReferenceBlood sugarDiabetes mellitus type 2Ketone bodiesHyperglycemia

Insulin resistance occurs when the body does a poor job of lowering blood sugars. Typically, patients with obesity and type 2 diabetes have fatty livers, and the dogma in the field, says Lazar, is that the fatty livers contribute to the insulin resistance and diabetes in a vicious cycle. These findings are "a clear counterexample to this thinking," he says.

The researchers observed that the extra fat in the liver did not cause insulin resistance because it was sequestered in tiny lipid droplets inside individual liver cells, coated by a specific protein. The metabolites that would otherwise be used by the body to make glucose were re-routed to make fat, leading to reduced glucose in the bloodstream. The advantage of the lower blood sugar is tempered by the excess liver fat, which can lead to problems of its own, including liver failure.

Cells of high-fat-diet-induced fatty livers in wild-type mice were characterized by larger lipid droplets, but liver-specific HDAC3 knockout mice on a high-fat diet were characterized by smaller lipid droplets, even though the total lipid content increased versus the wild-type mice.

Why would the body have this re-routing process in the first place? The team looked to the circadian rhythm of the nocturnal mice for answers. When inactive during the day, mouse HDAC3 migrates to genes to turn off fat synthesis. This allows metabolites to make glucose for fueling the sleeping body. When waking, during the night, the mouse body makes a metabolic switch, anticipating the intake of food, and turns on fat synthesis for energy storage. The on-and-off cycle of HDAC3 is directly regulated by the internal circadian clock, and the system falls apart when HDAC3 is deleted.

The findings suggest that the cordoning off of lipids of the liver in many, tiny coated droplets helps to manage insulin resistance in the body. And, the findings cement the fact that HDAC3 is pivotal in integrating signals from the internal body clock to coordinate metabolism, especially in the liver, notes the first author Zheng Sun, PhD, postdoctoral fellow in the Lazar lab.

The findings demonstrate that fat itself is not necessarily all bad. "It matters a lot how fat is handled and stored," notes Lazar. "It also highlights the importance of complying with our internal circadian clock. For example, since our body does not anticipate food at night and is preparing to generate more glucose, night-time eating is likely to shoot up blood sugar and thus may contribute to diabetes."

The work was funded in part by National Institute of Diabetes and Digestive and Kidney Diseases (R37 DK43806; P01 DK49210; R01 DK40936; R01 DK075017); the Cox Institute of Medical Research; and the JPB Foundation.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

View the Original article

New pregnancy risk for babies and moms: Overweight moms with moderately high blood sugar raise health risk

ScienceDaily (Apr. 11, 2012) — Pregnant women who are overweight with moderately elevated blood sugar never set off any alarms for their physicians. The big concern was for women who were obese or who had gestational diabetes because those conditions are known to cause a host of health risks to the mom and baby.

See Also:Health & MedicinePregnancy and ChildbirthObesityDiet and Weight LossDiabetesTeen HealthMenopauseReferenceBirth weightBlood sugarNutrition and pregnancyHyperglycemia

But a new study shows these women who are just above average for weight and blood sugar are at a higher risk of bad pregnancy outcomes than previously known. In fact, this group is at higher risk than pregnant women who are obese with normal blood sugar or pregnant women who have gestational diabetes and a normal weight.

"These are women who have not been on our radar because they don't have gestational diabetes and aren't obese, but our study shows if you are one step away from each of those, you carry some significant risks," said principle investigator Boyd Metzger, M.D., a professor of medicine-endocrinology at Northwestern University Feinberg School of Medicine and a physician at Northwestern Memorial Hospital. "We need to address the combination of overweight and blood sugar of these women as urgently as we do for women who are obese or have gestational diabetes."

This group of women comprised about 6 percent of the total number of women in the study. Obese women made up 16 percent of the group and those with gestational diabetes accounted for 13.7 percent.

The study also found women who are both obese and have gestational diabetes are at a much higher risk of having an adverse pregnancy than women having only one of those conditions.

The paper, published in the April issue of Diabetes Care, is from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study and includes 23,316 women from nine countries.

One of the adverse outcomes for these mothers is having large babies, the result of fat accumulation. Large babies increase the risk of injury to the baby during vaginal delivery, increasing the likelihood of a Caesarean section.

The study found when the mothers are obese and have gestational diabetes, the babies weigh 340 grams more than babies of mothers with normal weight and blood sugar. When the mothers are overweight (but not obese) with above-average blood sugar levels, the babies weigh 214 grams more. Mothers of normal weight but with gestational diabetes have babies who weigh 164 grams more. And obese mothers with normal glucose levels have babies with an increased weight of 174 grams.

A pregnant woman's higher blood sugar level and weight also can lead to higher insulin and lower blood sugar levels in a newborn. In turn, these effects may eventually trigger obesity and diabetes, perhaps as early as childhood.

"The big message from this is when you look at the impact of nutrition, metabolism and weight on pregnancy outcomes, every woman - on her first prenatal visit -- should get a prescription for a session with a dietician and an appropriate healthy eating plan for her pregnancy," said Metzger, also the Tom D. Spies Professor of Metabolism and Nutrition at Northwestern's Feinberg School. "This doesn't happen, but it should, and insurance companies should reimburse it."

The research is supported by the National Institutes of Health.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

View the Original article

Glycemic index foods at breakfast can control blood sugar throughout the day

ScienceDaily (Mar. 30, 2012) — Eating foods at breakfast that have a low glycemic index may help prevent a spike in blood sugar throughout the morning and after the next meal of the day, researchers said at the Institute of Food Technologists' Wellness 12 meeting.

See Also:Health & MedicineDiet and Weight LossNutritionObesityCholesterolDiabetesStaying HealthyReferenceSouth Beach dietGlycemic indexWhole grainBlood sugar

These breakfast foods also can increase feelings of satiety and fullness and may make people less likely to overeat throughout the day, according to recent presentations by Kantha Shelke, Ph.D., principal, Corvus Blue LLC, and Richard Mattes, M.P.H., R.D., distinguished professor of foods and nutrition at Purdue University.

The glycemic index ranks foods on the extent to which they raise blood sugar levels after eating. Foods with a high index are rapidly digested and result in high fluctuations in blood sugar levels. Foods with a low glycemic index produce gradual rises in blood sugar and insulin levels and are considered healthier, especially for people with diabetes.

Mattes' research specifically focused on the advantages of having almonds, a low glycemic index food, with the morning meal. In his study, published last year in the Journal of Nutrition and Metabolism, participants who ate a breakfast containing whole almonds experienced longer feelings of fullness and had lower blood glucose concentrations after breakfast and lunch, compared to those who did not have a low-glycemic breakfast.

When a low glycemic food is added to the diet, people spontaneously choose to eat less at other times throughout the day. Mattes added that while the calories need to be taken into consideration as part of a person's overall diet, almonds can be incorporated in moderate amounts without an effect on body weight.

Both Mattes and Shelke stressed the importance of eating a healthy, low-glycemic breakfast in maintaining a healthy weight and blood sugar levels. A 2009 study found that about 30 percent of people skip breakfast one to three times per week. Among those who eat breakfast, cold cereal is the most popular (83 percent), followed by eggs (71 percent). In addition to low glycemic index, Dr. Shelke said the ideal breakfast for consumers has these attributes:

• Savory

• Portable

• Pleasing texture •

Fills you up for extended periods of time

• Satiates quickly so less is consumed

• Affordable for the whole family to eat every day

• Non-fried

• Delicious without making you feeling guilty

"This is a very tall order for food product manufacturers," Shelke said. "It takes a lot of skill and understanding."

While it may present challenges for food manufacturers, it is well worth it to develop these products because of the prevalence of diabetes and pre-diabetes in the United States and beyond. It is estimated that by 2030, more than 16 percent of the global population will have a blood sugar problem.

"Most of the risk factors are things that can be managed and modified," Shelke said. "We can reverse pre-diabetes and prevent it from becoming diabetes. Food has become the reason for what's ailing us, but it can actually be a solution in a number of different ways."

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

View the Original article

Lipoic Acid Can Stop Retinal Damage from High Blood Sugar

Researchers from the Kresge Eye Institute of Wayne State University have found that R-alpha lipoic acid can break a vicious cycle of retinal damage associated with high blood sugar, a common and debilitating problem associated with Type 2 Diabetes.

This study is particularly interesting because once a person has high blood sugar, it triggers damage to the mitochondria Organelle found in cells that produce ATP or chemical energy. Also involved with cell signaling, cellular differentiation, cell death, cell growth, along with heme and steroid synthesis. (cell engines) within the retina, resulting in impaired energetic function and declining retinal health.  Unfortunately, even if blood sugar levels are brought down a vicious cycle of retinal damage persists. The study showed that R-alpha lipoic acid could reverse the problem in retinal mitochondria Organelle found in cells that produce ATP or chemical energy. Also involved with cell signaling, cellular differentiation, cell death, cell growth, along with heme and steroid synthesis. , restoring their energetic function to normal while arresting the progression of diabetic retinopathy. 

It is quite unfortunate that the obesity epidemic of today will result in a blindness epidemic within the next generation.  R-alpha lipoic acid shows the potential to save the eyesight of many people at risk for serious vision loss.

Share:
Supplements that contain lipoic acid
Related Entries:

Lipoic Acid Improves Blood Sugar Levels in Type 2 Diabetic Patients
How Carnosine and Lipoic Acid Stop Kidney Disease
Lipoic Acid and ALC Rejuvenate Muscle and Liver Energy Production
R-Alpha Lipoic Acid Corrects Insulin Signaling
R-Alpha Lipoic Acid Boosts Lifespan
Lipoic Acid Reduces Hardening of Arteries, Boosts Weight Loss

Other Health News

Pulling Data...

View the Original article

Sprinkles’ cupcake automat: A 24-hour sugar fix

PORC truck to open a restaurant in Columbia HeightsCooking Off the Cuff: Updating a classicPublic comments on vending regs due by 5 p.m. todayThe lamb brains are nice, but Batali just wants to hang outEntries By CategoryAll We Can EatBeerBooksChat LeftoversChefsComfort FoodFood PoliticsFood labelingHolidayIn SeasonMarkets This WeekMediaRecipesRestaurantsShoppingSmoke SignalsSpiritsSustainable FoodTales of the TestersTelevisionWineStories By DateFull Monthly Archive Posted at 01:30 PM ET, 03/03/2012By Cara Kelly


View the Original article

Sprinkles’ cupcake automat: A 24-hour sugar fix

PORC truck to open a restaurant in Columbia HeightsCooking Off the Cuff: Updating a classicPublic comments on vending regs due by 5 p.m. todayThe lamb brains are nice, but Batali just wants to hang outEntries By CategoryAll We Can EatBeerBooksChat LeftoversChefsComfort FoodFood PoliticsFood labelingHolidayIn SeasonMarkets This WeekMediaRecipesRestaurantsShoppingSmoke SignalsSpiritsSustainable FoodTales of the TestersTelevisionWineStories By DateFull Monthly Archive Posted at 01:30 PM ET, 03/03/2012By Cara Kelly

View the Original article